268 Results for "

Insulin secretion

" in MedChemExpress (MCE) Product Catalog:
Products (268)

268 Results for "Insulin secretion" in MCE Product Catalog:

45
45 Publications Verification
Art. -Nr.: HY-114118
CAS. Nr.: 910463-68-2
Reinheit:  99.84%
Semaglutide is a long-acting, selective, competitive GLP-1R agonist that can penetrate the blood-brain barrier. After activating GLP-1R, Semaglutide promotes insulin secretion, inhibits gastric emptying and appetite, and at the same time enhances autophagy, inhibits oxidative stress and apoptosis. Semaglutide also regulates mitochondrial function and lipid metabolism (such as reducing de novo lipogenesis in the liver). Semaglutide has activities such as lowering blood sugar, reducing weight, neuroprotection (such as improving motor function in Parkinson's disease models, reducing α-synuclein aggregation) and improving hepatic steatosis. Semaglutide can be used for the study of neurodegenerative diseases and liver diseases such as type 2 diabetes, obesity, Parkinson's disease, metabolic associated fatty liver disease (MASLD), and cancer .
loading...
    loading...
45
45 Publications Verification
Art. -Nr.: HY-114118B
CAS. Nr.: 1997361-85-9
Reinheit:  99.92%
Semaglutide acetate is a long-acting, selective, competitive GLP-1R agonist that can penetrate the blood-brain barrier. After activating GLP-1R, Semaglutide acetate promotes insulin secretion, inhibits gastric emptying and appetite, and at the same time enhances autophagy, inhibits oxidative stress and apoptosis. Semaglutide acetate also regulates mitochondrial function and lipid metabolism (such as reducing de novo lipogenesis in the liver). Semaglutide acetate has activities such as lowering blood sugar, reducing weight, neuroprotection (such as improving motor function in Parkinson's disease models, reducing α-synuclein aggregation) and improving hepatic steatosis. Semaglutide acetate can be used for the study of neurodegenerative diseases and liver diseases such as type 2 diabetes, obesity, Parkinson's disease, metabolic associated fatty liver disease (MASLD), and cancer .
loading...
    loading...
45
45 Publications Verification
Art. -Nr.: HY-114118A
Reinheit:  99.92%
Semaglutide TFA is a long-acting, selective, competitive GLP-1R agonist that can penetrate the blood-brain barrier. After activating GLP-1R, Semaglutide TFA promotes insulin secretion, inhibits gastric emptying and appetite, and at the same time enhances autophagy, inhibits oxidative stress and apoptosis. Semaglutide TFA also regulates mitochondrial function and lipid metabolism (such as reducing de novo lipogenesis in the liver). Semaglutide TFA has activities such as lowering blood sugar, reducing weight, neuroprotection (such as improving motor function in Parkinson's disease models, reducing α-synuclein aggregation) and improving hepatic steatosis. Semaglutide TFA can be used for the study of neurodegenerative diseases and liver diseases such as type 2 diabetes, obesity, Parkinson's disease, metabolic associated fatty liver disease (MASLD), and cancer .
loading...
    loading...
42
42 Cited Publications
Art. -Nr.: HY-P0014B
Target:  

GLP Receptor

Forschungsgebiete:  

Metabolic Disease

Liraglutide (TFA) is an agonist of glucagon-like peptide 1 receptor (GLP-1). Liraglutide (TFA) can activate GLP-1, leading to the release of insulin in the presence of increased glucose concentration. Liraglutide (TFA) also reduces glucagon secretion in a glucose-dependent manner. Liraglutide (TFA) can be studied in research on type 2 diabetes .
loading...
    loading...
12
12 Cited Publications
Art. -Nr.: HY-W016715
CAS. Nr.: 7048-04-6
L-Cysteine hydrochloride hydrate is an orally active and essential amino acid, which acts as a precursor for biologically active molecules such as hydrogen sulphide (H2S), glutathione and taurine. L-Cysteine hydrochloride hydrate regulates CBS/H2S pathway, inhibits NF-κB activation and insulin and ghrelin secretion. L-Cysteine hydrochloride hydrate reduces blood sugar, vascular inflammation markers and appetite. L-Cysteine hydrochloride hydrate induces kidney damage. L-Cysteine hydrochloride hydrate can be used in the study of neurological diseases and diabetes .
loading...
    loading...
11
11 Cited Publications
Art. -Nr.: HY-14734
CAS. Nr.: 249921-19-5
Reinheit:  99.94%
Synonyms: RC-1291; ONO-7643
Target:  

GHSR

Forschungsgebiete:  

Endocrinology Cancer

Anamorelin (RC-1291) is an orally active Ghrelin receptor agonist with an EC50 of 0.74 nM. Anamorelin can promote appetite, increase body weight, and stimulate the secretion of growth hormone and insulin-like growth factor-1. Anamorelin can be used in the research of anorexia and cancer cachexia .
loading...
    loading...
11
11 Cited Publications
Art. -Nr.: HY-14734A
CAS. Nr.: 861998-00-7
Reinheit:  99.59%
Synonyms: RC-1291 hydrochloride; ONO-7643 hydrochloride
Target:  

GHSR

Forschungsgebiete:  

Endocrinology Cancer

Anamorelin (RC-1291) hydrochloride is an orally active Ghrelin receptor agonist with an EC50 of 0.74 nM. Anamorelin hydrochloride can promote appetite, increase body weight, and stimulate the secretion of growth hormone and insulin-like growth factor-1. Anamorelin hydrochloride can be used in the research of anorexia and cancer cachexia .
loading...
    loading...
10
10 Cited Publications
Art. -Nr.: HY-P0055
CAS. Nr.: 106612-94-6
Target:  

GLP Receptor

Forschungsgebiete:  

Metabolic Disease

GLP-1(7-37) is an intestinal insulinotropic hormone that augments glucose induced insulin secretion.
loading...
    loading...
10
10 Cited Publications
Art. -Nr.: HY-P0054A
CAS. Nr.: 107444-51-9
Synonyms: Glucagon-like peptide-1 (GLP-1)(7-36), amide; Human GLP-1 (7-36), amide
Target:  

GCGR

Forschungsgebiete:  

Metabolic Disease

GLP-1(7-36), amide is a physiological incretin hormone that stimulates insulin secretion.
loading...
    loading...
10
10 Cited Publications
Art. -Nr.: HY-P0054
CAS. Nr.: 1119517-19-9
Synonyms: Glucagon-like peptide-1 (GLP-1)(7-36), amide acetate; Human GLP-1 (7-36), amide acetate
Target:  

GCGR

Forschungsgebiete:  

Metabolic Disease

GLP-1(7-36), amide acetate is a major intestinal hormone that stimulates glucose-induced insulin secretion from β cells.
loading...
    loading...
10
10 Cited Publications
Art. -Nr.: HY-P0055A
CAS. Nr.: 1450806-98-0
Target:  

GLP Receptor

Forschungsgebiete:  

Metabolic Disease

GLP-1(7-37) acetate is an intestinal insulinotropic hormone that augments glucose induced insulin secretion .
loading...
    loading...
10
10 Cited Publications
Art. -Nr.: HY-P0054B
Synonyms: Glucagon-like peptide-1 (GLP-1)(7-36), amide TFA; Human GLP-1 (7-36), amide TFA
Target:  

GCGR

Forschungsgebiete:  

Metabolic Disease

GLP-1(7-36), amide TFA is a major intestinal hormone that stimulates glucose-induced insulin secretion from β cells .
loading...
    loading...
8
8 Cited Publications
Art. -Nr.: HY-12717
CAS. Nr.: 50-60-2
Reinheit:  99.94%
Target:  

Adrenergic Receptor

Forschungsgebiete:  

Cardiovascular Disease Endocrinology

Phentolamine is an orally active, selective α1 and α2 Adrenergic receptor antagonist. Phentolamine antagonizes the vasodilatory effect of Cromakalim (HY-110011) on isolated circumflex coronary artery segments in dogs. Phentolamine reduces systemic vascular resistance and increases cardiac output. Phentolamine improves erectile dysfunction. Phentolamine can be used for the research of erectile dysfunction .
loading...
    loading...
7
7 Cited Publications
Art. -Nr.: HY-16307
CAS. Nr.: 261365-11-1
Target:  

FBPase

Forschungsgebiete:  

Metabolic Disease Cancer

MB05032 is a fructose-1,6-bisphosphatase (FBP1/FBPase) inhibitor with an IC50 value of 16 nM. MB05032 blocks FBP1-mediated glycolysis inhibition in NK cells, restores NK cell glucose uptake, lactate production, degranulation, perforin production, and cytotoxicity against gastric cancer cells. MB05032 elevates ATP/ADP ratios, increases glucose utilization, and enhances insulin secretion in pancreatic β-cells. MB05032 increases neutrophil adhesion, phagocytosis, and mRNA abundance of HKII, ITGA9, CD36 in subclinically hypocalcemic dairy cows. MB05032 inhibits gluconeogenesis in hepatocytes, acts as the active metabolite of prodrug Managlinat dialanetil (MB06322) (HY-14955). MB05032 can be used for the research of gastric cancer, type 2 diabetes, subclinical hypocalcemia, and insulin resistance .
loading...
    loading...
6
6 Cited Publications
Art. -Nr.: HY-108611
CAS. Nr.: 149301-79-1
Reinheit:  ≥99.0%
Synonyms: Arachidonyl trifluoromethyl ketone
Target:  

Phospholipase

Forschungsgebiete:  

Cardiovascular Disease

AACOCF3 (Arachidonyl trifluoromethyl ketone) is a cell-permeant trifluoromethyl ketone analog of arachidonic acid. AACOCF3 is a potent and selective slow binding inhibitor of the 85-kDa cytosolic phospholipase A2 (cPLA2). AACOCF3 blocks production of arachidonate and 12-hydroxyeicosatetraenoic acid by calcium ionophore-challenged platelets. AACOCF3 inhibits glucose-induced insulin secretion from isolated rat islets. AACOCF3 has the potential for the research of cardiovascular disease .
loading...
    loading...
6
6 Cited Publications
Art. -Nr.: HY-103192
CAS. Nr.: 40297-09-4
Reinheit:  99.82%
Synonyms: RMI12330A
Forschungsgebiete:  

Neurological Disease Cancer

MDL12330A (RMI12330A) is an adenylyl cyclases inhibitor. MDL12330A can inhibit KV channels, increases insulin secretion and Ca 2+ levels. MDL12330A accentuates contractions in uterine rings and inhibits cardiac functions. MDL12330A can be used for the research of endocrinology, metabolic and cardiovascular disease .
loading...
    loading...
5
5 Cited Publications
Art. -Nr.: HY-135897
CAS. Nr.: 165393-06-6
Reinheit:  ≥98.0%
Urolithin C, a gut-microbial metabolite of Ellagic acid, is a glucose-dependent activator of insulin secretion. Urolithin C is a L-type Ca 2+ channel opener and enhances Ca 2+ influx. Urolithin C induces cell apoptosis through a mitochondria-mediated pathway and also stimulates reactive oxygen species (ROS) formation .
loading...
    loading...
4
4 Cited Publications
Art. -Nr.: HY-125798
CAS. Nr.: 24967-27-9
Reinheit:  ≥98.0%
Synonyms: Neu5Ac2en; DANA
Target:  

Influenza Virus

Forschungsgebiete:  

Infection

N-acetyl-2,3-dehydro-2-Deoxyneuraminic Acid (Neu5Ac2en) is a potent neuraminidase (sialidase) inhibitor. N-acetyl-2,3-dehydro-2-Deoxyneuraminic Acid shows inhibitory activities against human neuraminidase enzymes with IC50s of 143, 43, 61, and 74 μM for NEU1, NEU2, NEU3, and NEU4, respectively. Anti-influenza virus activity .
loading...
    loading...
4
4 Cited Publications
Art. -Nr.: HY-117656
CAS. Nr.: 5184-64-5
Reinheit:  99.78%
Synonyms: NSC 116966
Target:  

Acyltransferase

Forschungsgebiete:  

Neurological Disease Metabolic Disease

ESI-05 is a specific exchange proteins directly activated by cAMP 2 (EPAC2) inhibitor. ESI-05 inhibits cAMP-mediated EPAC2 GEF activity with an IC50 of 0.43 μM. ESI-05 can be used for the research of diabetes, insulin secretion and neurological disorders .
loading...
    loading...
3
3 Cited Publications
Art. -Nr.: HY-W030796A
CAS. Nr.: 150436-68-3
Target:  

Taste Receptor

Forschungsgebiete:  

Metabolic Disease

Lactisole is a canonical antagonist of sweet taste receptor, selectively targeting to T1R3 subunit, a glucose-sensing receptor. Lactisole inhibits insulin secretion induced by glucose in mouse islets .
loading...
    loading...